pSvida to list on Nasdaq

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

WA-based biotech pSvida (ASX: PSD) is to reincorporate onto the Nasdaq, the American stock exchange.

The re-incorporation plan was first mooted in April. At a shareholders' meeting today, 94 per cent of shareholders, 192 in total, voted for the resolution, while six voted against it.

Between them the 192 shareholders hold around 96 per cent of the voting power.

The shareholders also voted to adopt a new employee incentive plan.

Related News

Sunscreen and supplements can lower your vitamin D levels

People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...

Low-dose drug prevents diabetes progression in young people

A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...

Mediterranean-style diet benefits maternal and infant health

Two studies have found that a Mediterranean-style diet benefits maternal health during pregnancy...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd